What Is Exosome Therapy?
Exosomes are extracellular vesicles — tiny membrane-bound particles secreted by cells — that carry a payload of growth factors, cytokines, and signaling molecules. In laboratory and early clinical research, exosomes have been shown to influence cell behavior, modulate inflammatory signaling, and may support tissue repair processes. Commercial exosome products used in orthopedics are typically derived from carefully screened donor tissue and processed to isolate these vesicles.
How Exosome Therapy May Work
Exosomes are administered via targeted injection, typically under imaging guidance. Because they are acellular — they do not contain whole cells — they interact with local tissue through the signaling molecules they carry rather than by engrafting or differentiating. Early research suggests they may help reduce inflammatory signaling and support cellular repair responses in injured or degenerative tissue. Most current evidence comes from preclinical and small clinical studies; robust randomized controlled trial data in orthopedics is still emerging.
What the Research Shows
Exosome research is an active and rapidly developing area. Laboratory studies and early human data are encouraging, particularly for conditions involving tendon injury, cartilage degeneration, and joint inflammation. However, exosome therapy for most orthopedic indications is still considered investigational. There are currently no FDA-approved exosome products for orthopedic use, and high-quality randomized controlled trials are limited. Physicians discuss current evidence, expected outcomes, and the investigational nature of this treatment honestly with every patient during consultation — in keeping with transparent, evidence-based care.
Safety and Regulatory Information
The FDA has expressed significant concern about certain commercial exosome products marketed with unsubstantiated claims of treating serious conditions. The FDA does not currently approve any exosome product for orthopedic use, and has taken enforcement action against products making unsupported treatment claims. When exosome therapy is offered at Key West Concierge Orthopedics, it is performed with products that meet applicable manufacturing and safety standards, under physician supervision, with full informed consent, and within the regulatory framework established under Florida law for biologic therapies. Patients are given clear, factual information about what is known and what remains uncertain before any decision is made.
Related Conditions
Is This Right for You?
Candidacy is determined after a thorough evaluation of your diagnosis, imaging, and treatment goals. Physicians at Key West Concierge Orthopedics will explain your options clearly during your consultation.
Sources
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies.
- U.S. Food and Drug Administration. Warning Letter: Liveyon LLC (exosome product safety enforcement example). 2019.
- Tao SC, et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee. Theranostics. 2017;7(18):4742–4758.
- Vonk LA, et al. Mesenchymal stromal/stem cell-derived extracellular vesicles promote human cartilage-specific marker expression and transcription factor activation in a three-dimensional pellet model. Theranostics. 2021.
- Florida Statutes, Section 458.3245. Stem cell therapy.